Intended for healthcare professionals


Thalassaemia: NHS to offer stem cell transplants to adults who need transfusions

BMJ 2023; 383 doi: (Published 30 November 2023) Cite this as: BMJ 2023;383:p2837
  1. Zosia Kmietowicz
  1. The BMJ

Adults who have transfusion dependent thalassaemia are being given access to stem cell transplantations on the NHS, a treatment previously available only to children.

Advances in transplant treatment, such as better drugs to manage a patient before, during, and after transplantation, mean that allogeneic haematopoietic stem cell transplant (HSCT) has been recommended for eligible adults over 18 in new guidance from NHS England’s clinical priorities advisory group.

Transfusion dependent thalassaemia is a severe form of the condition, …

View Full Text

Log in

Log in through your institution


* For online subscription